Correction to: Prospective multicentre randomized double‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
Crossref DOI link: https://doi.org/10.1007/s11255-023-03469-5
Published Online: 2023-01-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nestler, S.
Peschel, C.
Horstmann, A. H.
Vahlensieck, W.
Fabry, W.
Neisius, A.
Text and Data Mining valid from 2023-01-25
Version of Record valid from 2023-01-25
Article History
First Online: 25 January 2023